| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35194-1mg | |||
| Carrier-Free | NBP2-35194-100ug | |||
| Carrier-Free | NBP2-35194-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34905-1mg | |||
| Carrier-Free | NBP2-34905-100ug | |||
| Carrier-Free | NBP2-34905-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35293-1mg | |||
| Carrier-Free | NBP2-35293-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-61003-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-60973-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99331-50ul | |||
![SDS-Page: Rat FGF-21 Protein [NBP2-35194]](http://images.novusbio.com/fullsize/Rat-FGF-21-Protein-SDS-Page-NBP2-35194-img0001.jpg "SDS-Page: Rat FGF-21 Protein [NBP2-35194]")
![Western Blot: Fibrinogen gamma chain Antibody (5A6) [NBP2-37560] - Western blot analysis using FGG mAb against human FGG (AA: 210-437) recombinant protein. (Expected MW is 51.5 kDa)](http://images.novusbio.com/fullsize/Fibrinogen-gamma-chain-Antibody-5A6-Western-Blot-NBP2-37560-img0002.jpg "Western Blot: Fibrinogen gamma chain Antibody (5A6) [NBP2-37560] - Western blot analysis using FGG mAb against human FGG (AA: 210-437) recombinant protein. (Expected MW is 51.5 kDa)")
![Immunocytochemistry/Immunofluorescence: Fibrinogen gamma chain Antibody (5A6) [NBP2-37560] - Immunofluorescence analysis of NIH/3T3 cells using FGG mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/Fibrinogen-gamma-chain-Antibody-5A6-Immunocytochemistry-Immunofluorescence-NBP2-37560-img0003.jpg)
![ELISA: Fibrinogen gamma chain Antibody (5A6) [NBP2-37560] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/Fibrinogen-gamma-chain-Antibody-5A6-ELISA-NBP2-37560-img0001.jpg)
![SDS-Page: Human CXCL8/IL-8 72 a.a Protein [NBP2-34905]](http://images.novusbio.com/fullsize/Human-CXCL8-IL-8-72-a.a-Protein-SDS-Page-NBP2-34905-img0001.jpg "SDS-Page: Human CXCL8/IL-8 72 a.a Protein [NBP2-34905]")
![SDS-Page: Rat EGF Protein [NBP2-35293]](http://images.novusbio.com/fullsize/Rat-EGF-Protein-SDS-Page-NBP2-35293-img0001.jpg "SDS-Page: Rat EGF Protein [NBP2-35293]")
![<b>Biological Strategies Validation. </b>Western Blot: FGFR3 Antibody [NB600-1509] - (A) Western blot analysis of apoptotic markers following 24 & 48 hrs of selenite (5 μM), GS-Se-SG (5 μM) & Se-DL-cystine (100 μM) treatment. (B) Western blot analysis of autophagic & ER stress markers, evaluated after 1, 3, 6 & 18 hrs of treatment with selenite (5 μM), GS-Se-SG (5 μM) & Se-DL-cystine (100 μM). (C) Acridine orange staining of cells after 12 hrs of treatment with selenite (5 μM), GS-Se-SG (5 μM) & Se-DL-cystine (100 μM) (magnification 40 ×). (D) High-resolution transmission electron microscopy micrographs of control & 24 hrs Se-DL-cystine-treated cells, showing the presence of autophagosome, as evident from double-layered membrane structure with inclusion bodies. (E) Western blot detection of ubiquitinylated proteins after treatments with different selenium compounds (similar doses as previous) for 6 hrs. Five microgram cell lysate was loaded into each lane. The lane intensity was analysed by using Adobe Photoshop program (version CS5). beta -actin was used as a loading control (Fig. 4A & B). C: Control; 1: selenite; 2: GS-Se-SG; 3: Se-DL-cystine. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24400844), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1509_rabbit-polyclonal-fgfr3-antibody-310202416175253.jpg)
![Immunohistochemistry-Paraffin: Laminin Antibody (4C7) [NB120-17107] - Analysis in formalin fixed paraffin embedded renal carcinoma stained with Laminin Antibody (4C7) [NB120-17107].](http://images.novusbio.com/fullsize/Laminin-Antibody-4C7-Immunohistochemistry-Paraffin-NB120-17107-img0002.jpg "Immunohistochemistry-Paraffin: Laminin Antibody (4C7) [NB120-17107] - Analysis in formalin fixed paraffin embedded renal carcinoma stained with Laminin Antibody (4C7) [NB120-17107].")
![Immunohistochemistry-Paraffin: Laminin Antibody (4C7) [NB120-17107] - Analysis in formalin fixed paraffin embedded renal carcinoma with Laminin Antibody (4C7) [NB120-17107].](http://images.novusbio.com/fullsize/Laminin-Antibody-4C7-Immunohistochemistry-Paraffin-NB120-17107-img0001.jpg)
![Western Blot: FGFR2 Antibody [NB200-642] - Whole extract of HEK-293T cells expressing FGFR-2 were separated on SDS-PAGE and probed with Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit. The antibody was developed using 1:10,000 Goat Anti-Rabbit IgG-Peroxidase.Lanes:1. 0.5 ug/mL antibody2. 0.25 ug/mL antibody3. 0.5 ug/mL antibody untransfected 293T cells4. Negative Control](http://images.novusbio.com/fullsize/FGFR2-Antibody-Western-Blot-NB200-642-img0002.jpg "Western Blot: FGFR2 Antibody [NB200-642] - Whole extract of HEK-293T cells expressing FGFR-2 were separated on SDS-PAGE and probed with Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit. The antibody was developed using 1:10,000 Goat Anti-Rabbit IgG-Peroxidase.Lanes:1. 0.5 ug/mL antibody2. 0.25 ug/mL antibody3. 0.5 ug/mL antibody untransfected 293T cells4. Negative Control")
![Immunohistochemistry: FGFR2 Antibody [NB200-642] - Formalin fixed, paraffin-embedded Human placenta tissue sections were stained with 2 ug/mL Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit followed by 20 ug/mL Anti-Rabbit IgG (whole molecule)-Biotin antibody produced in Goat and by 20 ug/mL ExtrAvidin-Peroxidase.](http://images.novusbio.com/fullsize/FGFR2-Antibody-Immunohistochemistry-NB200-642-img0003.jpg)
![Western Blot: FGFR2 Antibody [NB200-642] - Antibody recognition: Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit is confirmed by western blot in the cell sample that has been altered to overexpress the target protein-HEK-293T over expressing Fibroblast Growth Factor Receptor-2 (Lane 1) while no staining is detected in the wild type sample-HEK-293T (Lane 2). The antibody was developed with 1:10,000 Goat Anti-Rabbit IgG-peroxidase and a chemiluminescent substrate.Antibody dilution: 0.5 ug/mL.](http://images.novusbio.com/fullsize/FGFR2-Antibody-Western-Blot-NB200-642-img0001.jpg)
![Immunohistochemistry: TIMP-4 Antibody (MM0037-9F3) [NB110-61003] - Formalin fixed and paraffin embedded normal human placenta tissue using NB110-61003](http://images.novusbio.com/fullsize/TIMP-4-Antibody-MM0037-9F3-Immunohistochemistry-NB110-61003-img0001.jpg "Immunohistochemistry: TIMP-4 Antibody (MM0037-9F3) [NB110-61003] - Formalin fixed and paraffin embedded normal human placenta tissue using NB110-61003")
![Immunohistochemistry-Paraffin: VEGFD Antibody (MM0007-7E79) [NB110-60973] - Formalin fixed and Paraffin embedded human placenta tissue section was subjected to IHC staining (Proteinase K pretreatment is required).](http://images.novusbio.com/fullsize/VEGFD-Antibody-MM0007-7E79-Immunohistochemistry-Paraffin-NB110-60973-img0003.jpg "<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: VEGFD Antibody (MM0007-7E79) [NB110-60973] - Formalin fixed and Paraffin embedded human placenta tissue section was subjected to IHC staining (Proteinase K pretreatment is required).")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: VEGFD Antibody (MM0007-7E79) [NB110-60973] - Formalin fixed and Paraffin embedded human placenta tissue section was subjected to IHC staining using NB110-60973 (Proteinase K pretreatment is required).](http://images.novusbio.com/fullsize/VEGFD-Antibody-MM0007-7E79-Immunohistochemistry-Paraffin-NB110-60973-img0002.jpg)
![Immunohistochemistry-Paraffin: MKK4/MEK4 Antibody [NBP2-99331] - Immunochemical staining of human MKK4/MEK4 in human skeletal muscle with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/MKK4-MEK4-Antibody-Immunohistochemistry-Paraffin-NBP2-99331-img0003.jpg "Immunohistochemistry-Paraffin: MKK4/MEK4 Antibody [NBP2-99331] - Immunochemical staining of human MKK4/MEK4 in human skeletal muscle with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.")
![Immunohistochemistry-Paraffin: MKK4/MEK4 Antibody [NBP2-99331] - Immunochemical staining of human MKK4/MEK4 in human breast carcinoma with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/MKK4-MEK4-Antibody-Immunohistochemistry-Paraffin-NBP2-99331-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: MKK4/MEK4 Antibody [NBP2-99331] - Immunofluorescence staining of MKK4/MEK4 in HeLa cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-99331 antibody (dilution ratio 1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor$488-conjugated Goat Anti-rabbit IgG Secondary antibody (green). Positive staining was localized to cytoplasm and nucleus.](http://images.novusbio.com/fullsize/nbp2-99331_rabbit-polyclonal-mkk4-mek4-antibody-23520252145179.png)